Home LiteratureArticle Details
PMID: 19128232 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Tumor growth-promoting properties of macrophage migration inhibitory factor.

Current pharmaceutical design ·Vol. 14 ·No. 36 ·2008-00-00 ·Pages 3790-801

Bifulco C, McDaniel K, Leng L, Bucala R

Abstract

Macrophage migration inhibitor factor (MIF) is a highly conserved and evolutionarily ancient mediator with pleiotropic effects that has been implicated in tumor growth and progression. MIF's function is unique among cytokines and its effects extend to multiple processes fundamental to tumorigenesis such as tumor proliferation, evasion of apoptosis, angiogenesis and invasion. These pleiotropic functional aspects are paralleled by MIF's unique signaling properties, which involve activation of the ERK-1/2 and AKT pathways and the regulation of JAB1, p53, SCF ubiquitin ligases and HIF-1. These properties reflect features central to growth regulation, apoptosis and cell cycle control than is typical for an immune cytokine. The significance of these pro-tumorigenic properties has found support in several in vitro and in vivo models of cancer and in the positive association between MIF production and tumor aggressiveness and metastatic potential in a variety of human tumors.

MeSH Terms
Cell Division/physiology Cell Transformation, Neoplastic Disease Progression Humans Macrophage Migration-Inhibitory Factors/chemistry,genetics,physiology Macrophages/cytology Neoplasm Invasiveness Neoplasms/blood supply,pathology Neovascularization, Pathologic Protein Conformation Signal Transduction
Chemicals
Macrophage Migration-Inhibitory Factors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Bifulco Carlo
Department of Medicine, Pathology, Epidemiology and Public Health, Yale University School of Medicine, 300 Cedar Street, New Haven, CT 06520-8031, USA.
McDaniel Katy
Leng Lin
Bucala Richard
Article Info
Journal
Current pharmaceutical design
Abbr.
Curr Pharm Des
ISSN
1873-4286
Published
2008-00-00
Pages
3790-801
Language
English
Region
United Arab Emirates
NLM ID
9602487
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com